Jogesh Harjai, MD
Emergency Medicine · Conroe, TXNPI 1326149931
Payments from drug & device makers
Across 27 payments — averaging $103.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Biotronik Inc.$249
- Boehringer Ingelheim$244
- Penumbra, Inc.$143
- Sanofi-aventis U.S. LLC$122
- Esperion Therapeutics, Inc.$119
- plus $691 from 8 others
What the payments were for
- Food & beverage$2,788100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 11 | $1,221 |
| Biotronik Inc. | 2 | $249 |
| Boehringer Ingelheim | 2 | $244 |
| Penumbra, Inc. | 1 | $143 |
| Sanofi-aventis U.S. LLC | 1 | $122 |
| Esperion Therapeutics, Inc. | 1 | $119 |
| AstraZeneca | 1 | $110 |
| Teva Pharmaceuticals USA, Inc. | 1 | $106 |
| Regeneron Healthcare Solutions, Inc. | 1 | $105 |
| Johnson & Johnson | 1 | $103 |
| Lilly USA, LLC | 2 | $94 |
| Abbott | 1 | $84 |
| Acarix USA Inc. | 1 | $47 |
| Pfizer | 1 | $43 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CoreValve Evolut$510
- COREVALVE EVOLUT R$459
- JARDIANCE$244
- Indigo$143
- IN.PACT Admiral$134
- DISEASE STATE$122
- NEXLIZET$119
- NEXLETOL$119
- LOKELMA$110
- AUSTEDO$106
- PRALUENT$105
- XARELTO$103
How this compares
$2,788 in reported general payments places this provider in the 95th percentile of 3,952 emergency medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 20 | $351 |
| Methylprednisolone | 29 | $226 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 30 | $136 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 22 | $133 |
| Naproxen | 46 | $123 |
| Ciprofloxacin Hcl | 15 | $92 |
| Ondansetron OdtOndansetron | 13 | $74 |
| Tizanidine Hcl | 17 | $56 |
| Cephalexin | 12 | $54 |
| Ibuprofen | 11 | $52 |
| Cyclobenzaprine Hcl | 17 | $41 |
| Prednisone | 27 | $32 |
| Tramadol Hcl | 11 | $15 |
Paid to pharmacies, not to this prescriber.
Other emergency medicine in Conroe
- Chad CrystalPalestine$26.8M
- Brian SpearsSan Antonio$12.9M
- Sinikka GreenAustin$10.2M
- James LillyDallas$8.5M
- Craig BoyleAustin$8M
- Alan HandSugar Land$6.8M
- Rebecca Wood-HorrallSmithville$5.9M
- Michael ZimmermanAustin$4.7M
- Bentley BobrowHouston$2.7M
- David WatsonFort Hood$2.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.